メトホルミンの世界市場レポート2025

メトホルミン市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.1％で58億8,000万米ドルに成長します。予測期間の成長は、新興市場の拡大、メトホルミンの認知度向上と採用、人口の高齢化、特許切れとジェネリック競争、併用療法の需要増加、副作用に対する意識の高まり、安全性への懸念などに起因すると考えられます。予測期間における主な動向としては、新製品の発売、生活習慣への介入、研究開発、パートナーシップの増加、製造技術の進歩などが挙げられます。

糖尿病の有病率の増加は、今後数年間のメトホルミン市場の成長を大きく促進すると予想されます。糖尿病は、膵臓で十分なインスリンが分泌されないか、分泌されたインスリンを体が効果的に使用できない場合に発症し、血糖値が高くなります。糖尿病の有病率上昇の要因としては、肥満の流行、遺伝的素因、不健康なライフスタイルの選択、ヘルスケアへのアクセスの制限、特定の環境毒素への暴露などが挙げられます。メトホルミンは、血糖値を下げ、インスリン感受性を改善し、体重減少をサポートし、心血管系に利益をもたらす可能性があるため、2型糖尿病の管理に重要な役割を果たします。例えば、Diabetes Canadaによると、2023年2月、カナダにおける糖尿病の推定患者数は、2023年の240万9,000人（人口の15％）から、2033年には300万9,000人（人口の17％）に増加すると予測されています。糖尿病の有病率が上昇を続ける中、メトホルミンの需要は拡大し、メトホルミン市場の拡大をさらに促進すると予測されています。

メトホルミン市場の主要企業は、市場ポジションを強化するため、3剤配合剤（FDC）などの革新的な糖尿病治療薬の開発に注力しています。3剤併用FDCは、3種類の異なる抗糖尿病薬を1つの錠剤またはカプセルに配合したもので、2型糖尿病患者の血糖値を相乗的に管理し、血糖コントロールを強化することを目的としています。例えば、インドのグレンマーク・ファーマシューティカルズ社は2023年10月、テネリグリプチンとダパグリフロジンおよびメトホルミンを配合したインド初の3剤併用FDCであるジータDMを発売しました。Zita DMは、テネリグリプチン（20mg）、ダパグリフロジン（10mg）、およびメトホルミンSR（500mg/1000mg）を固定用量で含有しており、成人2型糖尿病患者、特にメトホルミン単独で十分な血糖コントロールが得られない患者や追加治療が必要な患者において、血糖コントロールを改善するよう設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界メトホルミンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のメトホルミン市場：成長率分析
• 世界のメトホルミン市場の実績：規模と成長, 2019-2024
• 世界のメトホルミン市場の予測：規模と成長, 2024-2029, 2034F
• 世界メトホルミン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のメトホルミン市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準放出錠
• 徐放錠
• 世界のメトホルミン市場投与量別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 500MG
• 750MG
• 850MG
• 1G
• 世界のメトホルミン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• 病院
• ホームケア
• その他のエンドユーザー
• 世界のメトホルミン市場標準放出錠の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 500mg
• 850mg
• 1000mg
• 世界のメトホルミン市場徐放錠の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 500mg
• 750mg
• 1000mg

第7章 地域別・国別分析

• 世界のメトホルミン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のメトホルミン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• メトホルミン市場：競合情勢
• メトホルミン市場：企業プロファイル
  • Wockhardt Limited Overview, Products and Services, Strategy and Financial Analysis
  • Aarti Drugs Overview, Products and Services, Strategy and Financial Analysis
  • Abhilash Chemicals Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • Farmhispania Overview, Products and Services, Strategy and Financial Analysis
  • Rochem International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Jai Radhe Sales
• Chr. Olesen Group
• Aspire Lifesciences Pvt. Ltd.
• Ria Lifesciences Pvt. Ltd.
• Shree Sadguru
• LGM Pharma
• HRV Global Life Sciences
• Octavius Pharma Pvt. Ltd.
• USV Private Limited
• Zeon Pharma Industries India Pvt. Ltd.
• Atman Pharmaceuticals
• Aastrid International Pvt. Ltd.
• Abhilasha Pharma
• Anwita Drugs & Chemicals Pvt. Ltd.
• IOL Chemicals and Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• メトホルミン市場2029：新たな機会を提供する国
• メトホルミン市場2029：新たな機会を提供するセグメント
• メトホルミン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Metformin is an oral medication primarily used for managing type 2 diabetes, classified under the biguanides class of drugs. Its mechanism involves reducing glucose production in the liver, enhancing insulin sensitivity to promote glucose uptake by muscles, and decreasing glucose absorption from the intestines.

The main formulations of metformin include standard-release tablets and slow-release tablets. Standard-release tablets release the active ingredient quickly after ingestion, facilitating rapid control of blood sugar levels. Metformin is available in various dosages such as 500mg, 750mg, 850mg, and 1g, catering to diverse end-users including clinics, hospitals, homecare settings, and other healthcare providers.

The metformin market research report is one of a series of new reports from The Business Research Company that provides metformin market statistics, including metformin industry global market size, regional shares, competitors with a metformin market share, detailed metformin market segments, market trends, and opportunities, and any further data you may need to thrive in the metformin industry. This metformin research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The metformin market size has grown strongly in recent years. It will grow from $4.17 billion in 2024 to $4.48 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rise in the prevalence of diabetes, growth in awareness of diabetes, and increasing healthcare spending.

The metformin market size is expected to see strong growth in the next few years. It will grow to $5.88 billion in 2029 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to expansion in emerging markets, growing awareness, and adoption of metformin, aging Population, patent expiry and generic competition, increasing demand for combination therapies, increased awareness of side effects, and safety concerns. Major trends in the forecast period include the launch of new products, lifestyle interventions, research and development, increasing partnerships, and advancements in manufacturing technology.

The increasing prevalence of diabetes is expected to significantly propel the growth of the metformin market in the coming years. Diabetes occurs when the pancreas either does not produce enough insulin or when the body cannot effectively use the insulin it produces, leading to high blood sugar levels. Contributing factors to the rising prevalence of diabetes include the obesity epidemic, genetic predispositions, unhealthy lifestyle choices, limited access to healthcare, and exposure to certain environmental toxins. Metformin plays a crucial role in managing type 2 diabetes by lowering blood sugar levels, improving insulin sensitivity, supporting weight loss, and potentially offering cardiovascular benefits. For example, according to Diabetes Canada, in February 2023, the estimated number of diabetes cases in Canada was projected to increase from 2,409,000 (15% of the population) in 2023 to 3,009,000 (17% of the population) by 2033. As the prevalence of diabetes continues to rise, the demand for metformin is expected to grow, further driving the expansion of the metformin market.

Leading companies in the metformin market are focusing on developing innovative diabetes medications, such as triple-drug Fixed-Dose Combinations (FDC), to strengthen their market positions. A triple-drug FDC combines three different antidiabetic medications into a single tablet or capsule, aiming to synergistically manage blood sugar levels and enhance glycemic control in patients with type 2 diabetes. For instance, Glenmark Pharmaceuticals, an India-based company, launched Zita DM in October 2023, the first triple-drug FDC of teneligliptin with dapagliflozin and metformin in India. Zita DM contains teneligliptin (20 mg), dapagliflozin (10 mg), and metformin SR (500 mg/1000 mg) in a fixed dose, designed to improve glycemic control in adults with type 2 diabetes, especially those who do not achieve adequate control with metformin alone or require additional therapies.

In April 2023, SK Capital Partners LP, a US-based investment firm, acquired Apotex Pharmaceutical Holdings Inc. to expand its presence in the pharmaceutical industry. This acquisition positions SK Capital to leverage Apotex's extensive portfolio of generic medications, including metformin, strengthening its capabilities and market reach. Apotex Pharmaceutical Holdings Inc., headquartered in Canada, is recognized for its production of metformin and other essential pharmaceuticals.

Major companies operating in the metformin market are Wockhardt Limited, Aarti Drugs, Abhilash Chemicals Private Limited, Farmhispania, Rochem International Inc., Jai Radhe Sales, Chr. Olesen Group, Aspire Lifesciences Pvt. Ltd., Ria Lifesciences Pvt. Ltd., Shree Sadguru, LGM Pharma, HRV Global Life Sciences, Octavius Pharma Pvt. Ltd., USV Private Limited, Zeon Pharma Industries India Pvt. Ltd., Atman Pharmaceuticals, Aastrid International Pvt. Ltd., Abhilasha Pharma, Anwita Drugs & Chemicals Pvt. Ltd., IOL Chemicals and Pharmaceuticals, Gangwal Healthcare, Granules India Limited, Alekhya Drugs Pvt. Ltd, Angels Pharma India Private Limited, Auro Laboratories Ltd.

North America was the largest region in the metformin market in 2024. The regions covered in the metformin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metformin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metformin market consists of sales of glucophage, fortamet, glumetza, riomet, and linagliptin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metformin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metformin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metformin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metformin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Standard-Release Tablets; Slow-Release Tablets
• 2) By Dosage Type: 500MG; 750MG; 850MG; 1G
• 3) By End-user: Clinics; Hospitals; Homecare; Other End-Users
• Subsegments:
• 1) By Standard-Release Tablets: 500 Mg; 850 Mg; 1000 Mg
• 2) By Slow-Release Tablets: 500 Mg; 750 Mg; 1000 Mg
• Companies Mentioned: Wockhardt Limited; Aarti Drugs; Abhilash Chemicals Private Limited; Farmhispania; Rochem International Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metformin Market Characteristics

3. Metformin Market Trends And Strategies

4. Metformin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Metformin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metformin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metformin Market Growth Rate Analysis
• 5.4. Global Metformin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metformin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metformin Total Addressable Market (TAM)

6. Metformin Market Segmentation

• 6.1. Global Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard-Release Tablets
• Slow-Release Tablets
• 6.2. Global Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 500MG
• 750MG
• 850MG
• 1G
• 6.3. Global Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Homecare
• Other End-Users
• 6.4. Global Metformin Market, Sub-Segmentation Of Standard-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 500 Mg
• 850 Mg
• 1000 Mg
• 6.5. Global Metformin Market, Sub-Segmentation Of Slow-Release Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 500 Mg
• 750 Mg
• 1000 Mg

7. Metformin Market Regional And Country Analysis

• 7.1. Global Metformin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metformin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metformin Market

• 8.1. Asia-Pacific Metformin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metformin Market

• 9.1. China Metformin Market Overview
• 9.2. China Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metformin Market

• 10.1. India Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metformin Market

• 11.1. Japan Metformin Market Overview
• 11.2. Japan Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metformin Market

• 12.1. Australia Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metformin Market

• 13.1. Indonesia Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metformin Market

• 14.1. South Korea Metformin Market Overview
• 14.2. South Korea Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metformin Market

• 15.1. Western Europe Metformin Market Overview
• 15.2. Western Europe Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metformin Market

• 16.1. UK Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metformin Market

• 17.1. Germany Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metformin Market

• 18.1. France Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metformin Market

• 19.1. Italy Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metformin Market

• 20.1. Spain Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metformin Market

• 21.1. Eastern Europe Metformin Market Overview
• 21.2. Eastern Europe Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metformin Market

• 22.1. Russia Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metformin Market

• 23.1. North America Metformin Market Overview
• 23.2. North America Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metformin Market

• 24.1. USA Metformin Market Overview
• 24.2. USA Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metformin Market

• 25.1. Canada Metformin Market Overview
• 25.2. Canada Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metformin Market

• 26.1. South America Metformin Market Overview
• 26.2. South America Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metformin Market

• 27.1. Brazil Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metformin Market

• 28.1. Middle East Metformin Market Overview
• 28.2. Middle East Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metformin Market

• 29.1. Africa Metformin Market Overview
• 29.2. Africa Metformin Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metformin Market, Segmentation By Dosage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metformin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metformin Market Competitive Landscape And Company Profiles

• 30.1. Metformin Market Competitive Landscape
• 30.2. Metformin Market Company Profiles
  • 30.2.1. Wockhardt Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aarti Drugs Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abhilash Chemicals Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Farmhispania Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Rochem International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metformin Market Other Major And Innovative Companies

• 31.1. Jai Radhe Sales
• 31.2. Chr. Olesen Group
• 31.3. Aspire Lifesciences Pvt. Ltd.
• 31.4. Ria Lifesciences Pvt. Ltd.
• 31.5. Shree Sadguru
• 31.6. LGM Pharma
• 31.7. HRV Global Life Sciences
• 31.8. Octavius Pharma Pvt. Ltd.
• 31.9. USV Private Limited
• 31.10. Zeon Pharma Industries India Pvt. Ltd.
• 31.11. Atman Pharmaceuticals
• 31.12. Aastrid International Pvt. Ltd.
• 31.13. Abhilasha Pharma
• 31.14. Anwita Drugs & Chemicals Pvt. Ltd.
• 31.15. IOL Chemicals and Pharmaceuticals

32. Global Metformin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metformin Market

34. Recent Developments In The Metformin Market

35. Metformin Market High Potential Countries, Segments and Strategies

• 35.1 Metformin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metformin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metformin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer